Literature DB >> 11033433

The measurement of efficacy in the drug discovery agonist selection process.

T Kenakin1.   

Abstract

Mesh：

Substances：

Year:  1999        PMID： 11033433     DOI： 10.1016/s1056-8719(00)00070-8

Source DB:  PubMed          Journal:  J Pharmacol Toxicol Methods        ISSN： 1056-8719            Impact factor:   1.950


× No keyword cloud information.
  3 in total

1.  The selectivity of beta-adrenoceptor agonists at human beta1-, beta2- and beta3-adrenoceptors.

Authors:  Jillian G Baker
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

2.  The signaling and selectivity of α-adrenoceptor agonists for the human α2A, α2B and α2C-adrenoceptors and comparison with human α1 and β-adrenoceptors.

Authors:  Richard G W Proudman; Juliana Akinaga; Jillian G Baker
Journal:  Pharmacol Res Perspect       Date:  2022-10

3.  The selectivity of α-adrenoceptor agonists for the human α1A, α1B, and α1D-adrenoceptors.

Authors:  Richard G W Proudman; Jillian G Baker
Journal:  Pharmacol Res Perspect       Date:  2021-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.